Article metrics

Download PDFPDF

Original article
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

 

Online download statistics by month:

Online download statistics by month: March 2016 to April 2020

AbstractFullPdf
Mar 2016829519572
Apr 2016556518317
May 2016288378213
Jun 2016224350228
Jul 2016153507514
Aug 20161669670524
Sep 20161064451522
Oct 2016534432244
Nov 2016281329178
Dec 2016203281100
Jan 2017193290104
Feb 20174210566
Mar 2017312461
Apr 2017318765
May 2017216161
Jun 20174615259
Jul 201715713690
Aug 201723915656
Sep 2017596374126
Oct 201743828854
Nov 201748830469
Dec 201765940694
Jan 201843329977
Feb 201843028388
Mar 201836226288
Apr 201826719148
May 201842025773
Jun 201831719967
Jul 201820017363
Aug 201824117773
Sep 2018795346
Oct 20181268477
Nov 201816612383
Dec 201814912556
Jan 20191148345
Feb 20191309549
Mar 20191157433
Apr 20191117138
May 2019153113218
Jun 2019152127215
Jul 2019157126201
Aug 201912393238
Sep 201911187226
Oct 20199562259
Nov 2019130103124
Dec 201922618473
Jan 20201058551
Feb 20201187852
Mar 202014112255
Apr 2020167139112
Total14005109867145